A carregar...
Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation.
Seventy-two patients with advanced squamous-cell carcinomas of the head and neck were randomised to receive weekly intravenous methotrexate at doses of either 50 mg/m2 (low dose), 500 mg/m2 (medium dose), or 5 g/m2 (high dose). Patients who failed to respond after four treatments at their initial do...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1981
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1504451/ https://ncbi.nlm.nih.gov/pubmed/6781586 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|